Success Metrics

Clinical Success Rate
90.0%

Based on 27 completed trials

Completion Rate
90%(27/30)
Active Trials
11(21%)
Results Posted
41%(11 trials)
Terminated
3(6%)

Phase Distribution

Ph phase_1
3
6%
Ph phase_3
6
12%
Ph phase_2
11
21%
Ph phase_4
12
23%
Ph not_applicable
16
31%
Ph early_phase_1
2
4%

Phase Distribution

5

Early Stage

11

Mid Stage

18

Late Stage

Phase Distribution50 total trials
Early Phase 1First-in-human
2(4.0%)
Phase 1Safety & dosage
3(6.0%)
Phase 2Efficacy & side effects
11(22.0%)
Phase 3Large-scale testing
6(12.0%)
Phase 4Post-market surveillance
12(24.0%)
N/ANon-phased studies
16(32.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.4%

27 of 34 finished

Non-Completion Rate

20.6%

7 ended early

Currently Active

11

trials recruiting

Total Trials

52

all time

Status Distribution
Active(13)
Completed(27)
Terminated(7)
Other(5)

Detailed Status

Completed27
Recruiting9
unknown5
Withdrawn4
Terminated3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
52
Active
11
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (4.0%)
Phase 13 (6.0%)
Phase 211 (22.0%)
Phase 36 (12.0%)
Phase 412 (24.0%)
N/A16 (32.0%)

Trials by Status

completed2752%
recruiting917%
active_not_recruiting24%
withdrawn48%
terminated36%
unknown510%
not_yet_recruiting24%

Recent Activity

Clinical Trials (52)

Showing 20 of 52 trialsScroll for more
NCT05958342Phase 2

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

Recruiting
NCT06217562Phase 4

Vasopressin for Septic Shock Pragmatic Trial

Completed
NCT07614438Phase 2

Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,

Not Yet Recruiting
NCT05738148Phase 1

Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation

Active Not Recruiting
NCT06426407

Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator

Terminated
NCT02118467Phase 4

Vasoactive Drugs in Intensive Care Unit

Recruiting
NCT05568160Phase 3

Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

Active Not Recruiting
NCT04463394Early Phase 1

The Hemodynamic Effects of Vasopressin in Patients With Fontan Physiology

Completed
NCT06547892Phase 2

Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU

Recruiting
NCT06234592Not Applicable

The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock

Recruiting
NCT04501861Phase 3

Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:

Completed
NCT05506319Phase 4

Hypotension in the Weaning From Vasopressor Drugs

Completed
NCT06419075Phase 4

Tranexamic Acid in Vaginal Reconstructive Surgery

Withdrawn
NCT02975999Phase 2

Use of Vasopressin Following the Fontan Operation

Completed
NCT06422975

Registry of Patients in Shock Treated With Vasopressin

Recruiting
NCT06329063Not Applicable

Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study

Recruiting
NCT06329037Not Applicable

The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study

Recruiting
NCT04602767Phase 4

Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery

Recruiting
NCT05193370Phase 4

Angiotensin II vs. Vasopressin in Septic Shock

Withdrawn
NCT04053478Not Applicable

Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
52